Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis

Nicolaus Kröger, Toni Giorgino, Bart L. Scott, Markus Ditschkowski, Haefaa Alchalby, Francisco Cervantes, Alessandro Vannucchi, Mario Cazzola, Enrica Morra, Tatjana Zabelina, Margherita Maffioli, Arturo Pereira, Dietrich Beelen, H. Joachim Deeg, Francesco Passamonti

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Allogeneic hematopoietic stem cell transplantation (SCT) is the only curative option for patients with primary myelofibrosis (PMF), but information on its net advantage over conventional therapies is lacking. Using ad hoc statistical analysis, we determined outcomes in 438 patients

Original languageEnglish
Pages (from-to)3347-3350
Number of pages4
JournalBlood
Volume125
Issue number21
DOIs
Publication statusPublished - May 21 2015

Fingerprint

Primary Myelofibrosis
Stem Cell Transplantation
Stem cells
Statistical methods
Survival
Hematopoietic Stem Cell Transplantation
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Kröger, N., Giorgino, T., Scott, B. L., Ditschkowski, M., Alchalby, H., Cervantes, F., ... Passamonti, F. (2015). Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. Blood, 125(21), 3347-3350. https://doi.org/10.1182/blood-2014-10-608315

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. / Kröger, Nicolaus; Giorgino, Toni; Scott, Bart L.; Ditschkowski, Markus; Alchalby, Haefaa; Cervantes, Francisco; Vannucchi, Alessandro; Cazzola, Mario; Morra, Enrica; Zabelina, Tatjana; Maffioli, Margherita; Pereira, Arturo; Beelen, Dietrich; Deeg, H. Joachim; Passamonti, Francesco.

In: Blood, Vol. 125, No. 21, 21.05.2015, p. 3347-3350.

Research output: Contribution to journalArticle

Kröger, N, Giorgino, T, Scott, BL, Ditschkowski, M, Alchalby, H, Cervantes, F, Vannucchi, A, Cazzola, M, Morra, E, Zabelina, T, Maffioli, M, Pereira, A, Beelen, D, Deeg, HJ & Passamonti, F 2015, 'Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis', Blood, vol. 125, no. 21, pp. 3347-3350. https://doi.org/10.1182/blood-2014-10-608315
Kröger N, Giorgino T, Scott BL, Ditschkowski M, Alchalby H, Cervantes F et al. Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. Blood. 2015 May 21;125(21):3347-3350. https://doi.org/10.1182/blood-2014-10-608315
Kröger, Nicolaus ; Giorgino, Toni ; Scott, Bart L. ; Ditschkowski, Markus ; Alchalby, Haefaa ; Cervantes, Francisco ; Vannucchi, Alessandro ; Cazzola, Mario ; Morra, Enrica ; Zabelina, Tatjana ; Maffioli, Margherita ; Pereira, Arturo ; Beelen, Dietrich ; Deeg, H. Joachim ; Passamonti, Francesco. / Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. In: Blood. 2015 ; Vol. 125, No. 21. pp. 3347-3350.
@article{0eb97589deda457ea8b62773d6578638,
title = "Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis",
abstract = "Allogeneic hematopoietic stem cell transplantation (SCT) is the only curative option for patients with primary myelofibrosis (PMF), but information on its net advantage over conventional therapies is lacking. Using ad hoc statistical analysis, we determined outcomes in 438 patients",
author = "Nicolaus Kr{\"o}ger and Toni Giorgino and Scott, {Bart L.} and Markus Ditschkowski and Haefaa Alchalby and Francisco Cervantes and Alessandro Vannucchi and Mario Cazzola and Enrica Morra and Tatjana Zabelina and Margherita Maffioli and Arturo Pereira and Dietrich Beelen and Deeg, {H. Joachim} and Francesco Passamonti",
year = "2015",
month = "5",
day = "21",
doi = "10.1182/blood-2014-10-608315",
language = "English",
volume = "125",
pages = "3347--3350",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "21",

}

TY - JOUR

T1 - Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis

AU - Kröger, Nicolaus

AU - Giorgino, Toni

AU - Scott, Bart L.

AU - Ditschkowski, Markus

AU - Alchalby, Haefaa

AU - Cervantes, Francisco

AU - Vannucchi, Alessandro

AU - Cazzola, Mario

AU - Morra, Enrica

AU - Zabelina, Tatjana

AU - Maffioli, Margherita

AU - Pereira, Arturo

AU - Beelen, Dietrich

AU - Deeg, H. Joachim

AU - Passamonti, Francesco

PY - 2015/5/21

Y1 - 2015/5/21

N2 - Allogeneic hematopoietic stem cell transplantation (SCT) is the only curative option for patients with primary myelofibrosis (PMF), but information on its net advantage over conventional therapies is lacking. Using ad hoc statistical analysis, we determined outcomes in 438 patients

AB - Allogeneic hematopoietic stem cell transplantation (SCT) is the only curative option for patients with primary myelofibrosis (PMF), but information on its net advantage over conventional therapies is lacking. Using ad hoc statistical analysis, we determined outcomes in 438 patients

UR - http://www.scopus.com/inward/record.url?scp=84930006828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930006828&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-10-608315

DO - 10.1182/blood-2014-10-608315

M3 - Article

C2 - 25784679

AN - SCOPUS:84930006828

VL - 125

SP - 3347

EP - 3350

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

ER -